IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 139 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $386 | -23.9% | 44,349 | 0.0% | 0.00% | -40.0% |
Q4 2023 | $507 | +18.7% | 44,349 | 0.0% | 0.01% | +25.0% |
Q3 2023 | $427 | -9.5% | 44,349 | 0.0% | 0.00% | -20.0% |
Q2 2023 | $472 | +6.8% | 44,349 | +5.6% | 0.01% | +25.0% |
Q1 2023 | $442 | -15.2% | 42,008 | 0.0% | 0.00% | -20.0% |
Q4 2022 | $521 | -99.9% | 42,008 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $435,000 | -93.8% | 42,008 | -92.3% | 0.01% | -92.2% |
Q2 2021 | $6,977,000 | +15.1% | 542,131 | 0.0% | 0.06% | +6.7% |
Q1 2021 | $6,061,000 | -10.9% | 542,131 | -9.2% | 0.06% | -11.8% |
Q4 2020 | $6,801,000 | +26.6% | 597,090 | 0.0% | 0.07% | +11.5% |
Q3 2020 | $5,371,000 | -21.5% | 597,090 | -9.9% | 0.06% | -24.7% |
Q2 2020 | $6,841,000 | -24.8% | 662,896 | -26.5% | 0.08% | -36.7% |
Q1 2020 | $9,096,000 | -35.2% | 901,496 | -14.5% | 0.13% | -17.4% |
Q4 2019 | $14,030,000 | +37.3% | 1,054,096 | -11.5% | 0.16% | +26.0% |
Q3 2019 | $10,221,000 | +14.5% | 1,190,591 | +46.0% | 0.12% | +12.8% |
Q2 2019 | $8,924,000 | +6.8% | 815,691 | +32.1% | 0.11% | +5.8% |
Q1 2019 | $8,352,000 | +18.2% | 617,291 | -9.5% | 0.10% | +6.2% |
Q4 2018 | $7,067,000 | -35.3% | 682,147 | +15.2% | 0.10% | -26.0% |
Q3 2018 | $10,928,000 | -7.3% | 591,989 | -4.0% | 0.13% | -5.8% |
Q2 2018 | $11,792,000 | +23.9% | 616,747 | 0.0% | 0.14% | +20.9% |
Q1 2018 | $9,516,000 | +2.9% | 616,747 | 0.0% | 0.12% | +5.5% |
Q4 2017 | $9,245,000 | -14.3% | 616,747 | -9.8% | 0.11% | -16.2% |
Q3 2017 | $10,786,000 | +38.8% | 683,980 | +66.1% | 0.13% | +34.0% |
Q2 2017 | $7,773,000 | +129.1% | 411,693 | +107.0% | 0.10% | +125.6% |
Q1 2017 | $3,393,000 | +3.3% | 198,889 | -7.4% | 0.04% | +2.4% |
Q4 2016 | $3,284,000 | -3.7% | 214,730 | 0.0% | 0.04% | -2.3% |
Q3 2016 | $3,410,000 | +26.2% | 214,730 | +4.0% | 0.04% | +19.4% |
Q2 2016 | $2,701,000 | +23.4% | 206,530 | +3.2% | 0.04% | +28.6% |
Q1 2016 | $2,189,000 | +2.9% | 200,030 | +9.0% | 0.03% | +3.7% |
Q4 2015 | $2,127,000 | +14.4% | 183,578 | +2.8% | 0.03% | +12.5% |
Q3 2015 | $1,860,000 | -13.6% | 178,578 | 0.0% | 0.02% | -7.7% |
Q2 2015 | $2,153,000 | -30.3% | 178,578 | -7.5% | 0.03% | -27.8% |
Q1 2015 | $3,090,000 | +4.4% | 193,105 | 0.0% | 0.04% | +5.9% |
Q4 2014 | $2,959,000 | +18.3% | 193,105 | 0.0% | 0.03% | +13.3% |
Q3 2014 | $2,502,000 | -15.5% | 193,105 | 0.0% | 0.03% | -11.8% |
Q2 2014 | $2,960,000 | +25.8% | 193,105 | +1.1% | 0.03% | +21.4% |
Q1 2014 | $2,353,000 | +19.4% | 191,005 | +12.5% | 0.03% | +21.7% |
Q4 2013 | $1,971,000 | +1.7% | 169,760 | +3.7% | 0.02% | +27.8% |
Q3 2013 | $1,938,000 | +19.6% | 163,690 | +0.3% | 0.02% | +20.0% |
Q2 2013 | $1,621,000 | – | 163,250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
13D Management LLC | 658,017 | $7,357,000 | 2.72% |
Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |